ImmunityBio Inc. Common Stock vs Sumitomo Mitsui Financial Group Inc Unsponsored American Depositary Shares (Japan) — how do they compare? ImmunityBio Inc. Common Stock trades at $10.01 (market cap $10.33B), while Sumitomo Mitsui Financial Group Inc Unsponsored American Depositary Shares (Japan) trades at $24.85 (market cap $160.34B). The key difference: Sumitomo Mitsui Financial Group Inc Unsponsored American Depositary Shares (Japan) is far larger — about 15.5× ImmunityBio Inc. Common Stock's market cap, and Sumitomo Mitsui Financial Group Inc Unsponsored American Depositary Shares (Japan) pays a 2.33% dividend while ImmunityBio Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 0 Days and Sumitomo Mitsui Financial Group Inc Unsponsored American Depositary Shares (Japan) for 0 Days on average.
| IBRX | SMFG | |
|---|---|---|
Market Cap | $10.33B | $160.34B |
Volume | 11,745,198 | 2,067,536 |
Sector | Health | Financials |
52-Week High | $11.55 | $27.56 |
52-Week Low | $1.98 | $15.20 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $10.79B | $12.79T |
Dividend Yield | — | 2.33% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →Sumitomo Mitsui Financial Group is a Japanese financial services company with banking, securities, leasing, and asset management businesses. It serves retail, corporate, and institutional clients.
Read more on SMFG →